We say farewell to Jorge Combarros today. Jorge has been on a 2-month secondment from Gadea Grupo Farmacéutico in Valladolid (part of AmriGlobal). His project is part of a larger EU collaboration, 3DNet, led by Dr Breandán Kennedy (UCD School of Biomolecular & Biomedical Science). While in Dublin he has worked on the synthesis of new molecules that will be tested as therapeutics for diseases of the eye. Jorge has done great work in this regard. In addition he has taught us a lot about working in industry, and about the techniques he has experise in. This ‘transfer-of-knowledge’ is a key goal of the FP7- Marie Curie IAPP grant that funded the secondment. We wish Jorge all the best for his future.